Plasma B-type natriuretic peptide measurement is not useful as a screening method for carriers of familial hypertrophic cardiomyopathy

被引：0
|
作者：
Brito, D.
de Oliveira, E. Infante
Richard, P.
Komajda, M.
Madeira, H.
机构：
[1] Univ Lisbon, Fac Med, Clin Cardiol, P-1699 Lisbon, Portugal
[2] GH Pitie Salpetriere, UF Cardiogenet & Mycogenet, Paris, France
[3] CHU Pitie Salpetriere, Paris, France
来源：
EUROPEAN HEART JOURNAL | 2005年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：389 / 389
页数：1
相关论文
共 50 条
  • [21] Usefulness of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy
    Maron, BJ
    Tholakanahalli, VN
    Zenovich, AG
    Casey, SA
    Duprez, D
    Aeppli, DM
    Cohn, JN
    CIRCULATION, 2004, 109 (08) : 984 - 989
  • [22] Plasma levels of A- and B-type natriuretic peptides in patients with hypertrophic cardiomyopathy or idiopathic dilated cardiomyopathy
    Mizuno, Y
    Yoshimura, M
    Harada, E
    Nakayama, M
    Sakamoto, T
    Shimasaki, Y
    Ogawa, H
    Kugiyama, K
    Saito, Y
    Nakao, K
    Yasue, H
    AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (09): : 1036 - 1040
  • [23] Association of elevated plasma B-type natriuretic peptide levels with paroxysmal atrial fibrillation in patients with nonobstructive hypertrophic cardiomyopathy
    Matsuura, Hiroko
    Murakami, Takashi
    Hina, Kazuyoshi
    Yamamoto, Keizo
    Kawamura, Hiroshi
    Sogo, Taiji
    Shinohata, Ryoko
    Usui, Shinichi
    Ninomiya, Yoshifumi
    Kusachi, Shozo
    CLINICAL BIOCHEMISTRY, 2008, 41 (03) : 134 - 139
  • [24] The role of plasma N-terminal pro B-type natriuretic peptide to predict the clinical course of patients with hypertrophic cardiomyopathy
    Bayrak, Fatih
    Kahveci, Gokhan
    Fotbolcu, Hakan
    Tigen, Kurflat
    Mutlu, Bulent
    Baflaran, Yelda
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2005, 33 (02): : 77 - 83
  • [25] B-type natriuretic peptide levels in patients with hypertrophic obstructive cardiomyopathy treated with alcohol septal ablation
    Tann, SM
    Nielsen, C
    Killip, D
    Feldman, DS
    Spencer, WH
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 144A - 144A
  • [26] B-type natriuretic peptide measurement in heart failure
    Spevack, DM
    Schwartzbard, A
    CLINICAL CARDIOLOGY, 2004, 27 (09) : 489 - 494
  • [27] B-type natriuretic peptide
    Granel, B
    REVUE DE MEDECINE INTERNE, 2004, 25 (04): : 299 - 302
  • [28] B-type natriuretic peptide
    Kandil, Emad
    Burack, Joshua
    Sawas, Ahmed
    Bibawy, Haidy
    Schwartzman, Alex
    Zenilman, Michael E.
    Bluth, Martin H.
    ARCHIVES OF SURGERY, 2008, 143 (03) : 242 - 246
  • [29] B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are comparably useful for disease monitoring in heart failure
    Hammerer-Lercher, A
    Pölzl, G
    Falkensammer, G
    Ludwig, W
    Hügel, H
    Puschendorf, B
    Pachinger, O
    Mair, J
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006, 106 (03) : 415 - 417
  • [30] Secretion patterns of A-type and B-type natriuretic peptides in patients with hypertrophic cardiomyopathy or dilated cardiomyopathy
    Mizuno, Y
    Yoshimura, M
    Nakayama, M
    Harada, E
    Nakamura, S
    Ito, T
    CIRCULATION, 2000, 102 (18) : 504 - 504
12345